TRDA Operating Cash Flow (Statement)
Entrada Therapeutics Inc · Operating Cash Flow (Statement)
TRDA Operating Cash Flow (Statement)
Latest reported-$134.67Mperiod ending
TRDA TTM Cash from Operations (-$25.57M → -$134.67M)
TTM operating cash flow (statement)
High-resolution chart · PNG
TRDA operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -134,674,000 | |
| -131,700,000 | |
| -128,512,000 | |
| -127,914,000 | |
| -123,867,000 | |
| -54,545,000 | |
| -41,557,000 | |
| -13,965,000 | |
| -14,191,000 | |
| -89,115,000 | |
| 139,803,000 | |
| 116,512,000 | |
| 113,522,000 | |
| 130,604,000 | |
| -93,786,000 | |
| -87,023,000 | |
| -73,616,000 | |
| -63,517,000 | |
| -50,862,000 | |
| -36,945,000 | |
| -28,515,000 | |
| -27,255,500 | |
| -25,570,000 |